The results demonstrate that PIM1 is highly expressed in 75% (9/12) of patients with ETP-ALL and in 13% (5/40) of non-ETP ALL (p = 0.00047; Figure 3A). Here, PIM1 is linked to acute lymphoblastic leukemia.